U S Physical Therapy Inc /Nv (USPH) Stock Price & Analysis
U S Physical Therapy Inc /Nv (USPH) rose 0.82% to USD 61.8 as of June 10, 2026 at 04:05 UTC, according to Nexqual real-time market data.
USPH last closed at USD 61.3; the session ranged USD 61.59–63.08 on volume of 148,005 shares. Market capitalization is $940.52M, with a 52-week range of USD 58.19–93.5 (NYQ). Source: Nexqual, June 10, 2026 at 04:05 UTC.
Key Statistics (as of June 10, 2026 at 04:05 UTC)
| Price | USD 61.8 |
|---|---|
| Change | ▲ 0.82% (up) |
| Previous Close | USD 61.3 |
| Open | USD 61.5 |
| Day Range | USD 61.59 – 63.08 |
| 52-Week Range | USD 58.19 – 93.5 |
| Volume | 148,005 shares |
| Market Cap | $940.52M |
| Exchange | NYQ |
Technical Analysis (USPH)
Nexqual's technical model rates USPH "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 04:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.96 (neutral) |
| vs SMA50 | Below (USD 69.17) |
| MACD | -1.89 (negative) |
Analyst Ratings (USPH)
Wall Street analysts rate USPH "None" based on 6 analysts, with a mean price target of USD 93.67 (range USD 88–100), per Nexqual as of June 10, 2026 at 04:05 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 93.67 |
| High Target | USD 100 |
| Low Target | USD 88 |
| Buy / Hold / Sell | 6 / 1 / 0 |
Earnings (USPH)
| Next Earnings Date | 2026-08-05 |
|---|---|
| EPS Estimate | USD 0.82 |
| Revenue Estimate | $211.36M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.46 vs est 0.52 ▼ miss |
| 2025-12-31 | USD 0.67 vs est 0.67 ▼ miss |
| 2025-09-30 | USD 0.66 vs est 0.66 ▲ beat |
| 2025-06-30 | USD 0.81 vs est 0.69 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:05 UTC.
Financials & Fundamentals (USPH)
| Total Revenue | $787.68M |
|---|---|
| Revenue Growth (YoY) | +7.90% |
| Gross Margin | +21.90% |
| Operating Margin | +7.34% |
| Profit Margin | +4.41% |
| ROE | +6.83% |
| Debt / Equity | 46.35 |
| Current Ratio | 1.19 |
| Total Cash | $29.49M |
| Total Debt | $362.83M |
| Free Cash Flow | $43.06M |
Source: Nexqual, June 10, 2026 at 04:05 UTC.
Financial Health Score (USPH)
Nexqual rates U S Physical Therapy Inc /Nv's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 04:05 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 22%, operating 7% |
| Balance Sheet | Solid — $29M cash vs $363M debt |
| Cash Flow | Solid — FCF $43M, 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 4.1% |
Ownership (USPH)
| Insider Ownership | +2.47% |
|---|---|
| Institutional Ownership | +108.38% |
| Shares Outstanding | 15.22M |
| Float | 14.85M |
| Short % of Float | +8.18% |
Source: Nexqual, June 10, 2026 at 04:05 UTC.
Leadership (USPH)
U S Physical Therapy Inc /Nv is led by Christopher J. Reading (age 61), CEO & Chairman, per Nexqual as of June 10, 2026 at 04:05 UTC.
| CEO & Chairman | Christopher J. Reading (age 61) |
|---|---|
| President & COO | Eric Joseph Williams (age 59) |
| Chief Operating Officer - West | Graham D. Reeve M.B.A., P.T. (age 61) |
| CEO of Metro & Director | Michael G. Mayrsohn (age 38) |
| Interim CFO and Senior VP of Finance & Accounting | Jason T. Curtis (age 49) |
Major Backers & Investors (USPH)
Notable institutional backers of U S Physical Therapy Inc /Nv include Kayne Anderson Rudnick Investment Management LLC, Morgan Stanley, Bahl & Gaynor, Inc., according to Nexqual as of June 10, 2026 at 04:05 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 7% |
| Morgan Stanley | 6.59% |
| Bahl & Gaynor, Inc. | 5.55% |
| Copeland Capital Management, LLC | 5.5% |
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 3.7% |
| ETF Series Solutions-Bahl & Gaynor Small/Mid Cap Income Growth ETF | 3.66% |
| Bank of America Corporation | 3.64% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 22.92% |
| Vanguard Group | 8.62% |
| State Street | 4.26% |
Source: Nexqual, June 10, 2026 at 04:05 UTC.
From U S Physical Therapy Inc /Nv's Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.
- It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.
- The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
- It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UTMD | Utah Medical Products, Inc. | USD 68.07 | ▲ 0.62% |
| SEM | Select Medical Holdings Corpora | USD 16.63 | ▲ 0.54% |
| ADUS | Addus HomeCare Corporation | USD 92.7 | ▲ 0.65% |
| NHC | National HealthCare Corporation | USD 192.12 | ▼ 0.01% |
| ENSG | The Ensign Group, Inc. | USD 155.25 | ▼ 8.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:05 UTC. This page is informational and not investment advice.